人工智能在结肠镜检查中检测腺瘤和息肉的性能:系统评价与荟萃分析
该系统评价与荟萃分析检索截至2020年3月的随机对照试验,纳入5项RCT共4354例患者,评估计算机辅助息肉检测(CADe)系统对结直肠肿瘤检测的性能。CADe组腺瘤检出率显著高于对照组(36.6% vs 25.2%;RR 1.44;95%CI 1.27-1.62;P<.01;I²=42%),每结肠镜腺瘤数亦升高(RR 1.70),效应独立于腺瘤大小、形态和位置等主要特征;RCT证据等级评为中等。
要点
- CADe组腺瘤检出率36.6%(791/2163)vs 对照组25.2%(558/2191),RR 1.44(95%CI 1.27-1.62;P<.01;I²=42%)。
- CADe组每结肠镜腺瘤数高于对照组(.58 vs .36;RR 1.70;95%CI 1.53-1.89;P<.01;I²=33%)。
- CADe组每结肠镜无蒂锯齿状病变数亦高于对照组(RR 1.52;95%CI 1.14-2.02)。
核心结论
- 根据现有证据,将人工智能作为结直肠肿瘤检测辅助手段可使结直肠肿瘤检出显著增加,且该效应独立于腺瘤主要特征。
- RCT证据等级评为中等。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、EMBASE和Cochrane Central数据库截至2020年3月,纳入报告CADe系统检测结直肠肿瘤诊断准确性的随机对照试验。
- 最终分析纳入5项随机对照试验,共4354例患者。
- 计算风险比(RR),进行亚组和敏感性分析,并评估异质性和发表偏倚。
主要发现
- CADe组腺瘤检出率显著高于对照组(791/2163 [36.6%] vs 558/2191 [25.2%];RR 1.44;95%CI 1.27-1.62;P<.01;I²=42%)。
- CADe组每结肠镜腺瘤数高于对照组(1249/2163 [.58] vs 779/2191 [.36];RR 1.70;95%CI 1.53-1.89;P<.01;I²=33%)。
- 腺瘤≤5mm(RR 1.69;95%CI 1.48-1.84)、6-9mm(RR 1.44;95%CI 1.19-1.75)和≥10mm(RR 1.46;95%CI 1.04-2.06)的每结肠镜腺瘤数均较高。
- 近端(RR 1.59;95%CI 1.34-1.88)、远端(RR 1.68;95%CI 1.50-1.88)、平坦型(RR 1.78;95%CI 1.47-2.15)和息肉样形态(RR 1.54;95%CI 1.40-1.68)的每结肠镜腺瘤数均较高。
- CADe组每结肠镜无蒂锯齿状病变数高于对照组(RR 1.52;95%CI 1.14-2.02),进展期腺瘤检出率呈非显著趋势(RR 1.35;95%CI .74-2.47;P=.33;I²=69%)。
关键数值与推荐
- CADe组腺瘤检出率36.6%(791/2163)vs 对照组25.2%(558/2191),RR 1.44(95%CI 1.27-1.62;P<.01;I²=42%)。
- CADe组每结肠镜腺瘤数.58(1249/2163)vs 对照组.36(779/2191),RR 1.70(95%CI 1.53-1.89;P<.01;I²=33%)。
- CADe组每结肠镜无蒂锯齿状病变数高于对照组,RR 1.52(95%CI 1.14-2.02)。
- 进展期腺瘤检出率CADe组与对照组比较无显著差异,RR 1.35(95%CI .74-2.47;P=.33;I²=69%)。
- RCT证据等级评为中等。
临床怎么用
- 原文未据此给出推荐。
局限性
- RCT证据等级评为中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: One-fourth of colorectal neoplasia are missed at screening colonoscopy, representing the main cause of interval colorectal cancer. Deep learning systems with real-time computer-aided polyp detection (CADe) showed high accuracy in artificial settings, and preliminary randomized controlled trials (RCTs) reported favorable outcomes in the clinical setting. The aim of this meta-analysis was to summarize available RCTs on the performance of CADe systems in colorectal neoplasia detection. METHODS: We searched MEDLINE, EMBASE, and Cochrane Central databases until March 2020 for RCTs reporting diagnostic accuracy of CADe systems in the detection of colorectal neoplasia. The primary outcome was pooled adenoma detection rate (ADR), and secondary outcomes were adenoma per colonoscopy (APC) according to size, morphology, and location; advanced APC; polyp detection rate; polyps per colonoscopy; and sessile serrated lesions per colonoscopy. We calculated risk ratios (RRs), performed subgroup and sensitivity analyses, and assessed heterogeneity and publication bias. RESULTS: Overall, 5 randomized controlled trials (4354 patients) were included in the final analysis. Pooled ADR was significantly higher in the CADe group than in the control group (791/2163 [36.6%] vs 558/2191 [25.2%]; RR, 1.44; 95% confidence interval [CI], 1.27-1.62; P < .01; I2 = 42%). APC was also higher in the CADe group compared with control (1249/2163 [.58] vs 779/2191 [.36]; RR, 1.70; 95% CI, 1.53-1.89; P < .01; I2 = 33%). APC was higher for ≤5-mm (RR, 1.69; 95% CI, 1.48-1.84), 6- to 9-mm (RR, 1.44; 95% CI, 1.19-1.75), and ≥10-mm adenomas (RR, 1.46; 95% CI, 1.04-2.06) and for proximal (RR, 1.59; 95% CI, 1.34-1.88), distal (RR, 1.68; 95% CI, 1.50-1.88), flat (RR, 1.78; 95% CI, 1.47-2.15), and polypoid morphology (RR, 1.54; 95% CI, 1.40-1.68). Regarding histology, CADe resulted in a higher sessile serrated lesion per colonoscopy (RR, 1.52; 95% CI, 1.14-2.02), whereas a nonsignificant trend for advanced ADR was found (RR, 1.35; 95% CI, .74-2.47; P = .33; I2 = 69%). Level of evidence for RCTs was graded as moderate. CONCLUSIONS: According to available evidence, the incorporation of artificial intelligence as aid for detection of colorectal neoplasia results in a significant increase in the detection of colorectal neoplasia, and such effect is independent from main adenoma characteristics.
引用
- Hassan C, Spadaccini M, Iannone A, et al. Performance of artificial intelligence in colonoscopy for adenoma and polyp detection: a systematic review and meta-analysis. Gastrointest Endosc. 2020. PMID: 32598963. doi:10.1016/j.gie.2020.06.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。